Bridge 2 Health Overview
- Founded
-
2022

- Status
-
Private
- Employees
-
1

- Latest Deal Type
-
Early Stage VC
- Investors
-
4
Bridge 2 Health General Information
Description
The company's tools assist in early discoveries, state-of-the-art in vitro and in vivo models, as well as a phase I unit, up to clinical studies to test and validate innovations and products across different stages of development and offer the infrastructures, and logistical facilities necessary for successful development of biotech, life sciences and medical device companies, enabling researchers and clinicians to jointly identify and accelerate the development of healthcare products.
Contact Information
Website
www.b2h.be
Formerly Known As
SCINNAMIC
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Media and Information Services (B2B)
Drug Discovery
Primary Office
- Parking St-DenParking St-Denis (7 étage) Rue Lambert Lois (7 étage) Rue Lambert Lombard, 5
- 4000 Liege
- Belgium
+32 04 000 00 00
Bridge 2 Health Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Early Stage VC | Completed | Startup |
Bridge 2 Health Executive Team (7)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Marylène Dominique | CCO | ||
Amel Tounsi Ph.D | Chief Executive Officer | ||
Aline Lausberg | Chief Financial Officer |
Bridge 2 Health Signals
Bridge 2 Health Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Centre Hospitalier Universitaire de Liège | Corporation | Minority | 000 0000 | 000000 0 | |
Noshaq | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Portail de la Wallonie | Other | Minority | 000 0000 | 000000 0 | |
University of Liege | University | Minority | 000 0000 | 000000 0 |